MFS Emerging Markets Debt I MEDIX

Medalist Rating as of | See MFS Investment Hub
  • NAV / 1-Day Return 12.35  /  −0.14 %
  • Total Assets 7.4 Bil
  • Adj. Expense Ratio
    0.810%
  • Expense Ratio 0.810%
  • Distribution Fee Level Average
  • Share Class Type Institutional
  • Category Emerging Markets Bond
  • Credit Quality / Interest Rate Sensitivity Low/Extensive
  • Min. Initial Investment 0
  • Status Open
  • TTM Yield 6.78%
  • Effective Duration 6.90 years

USD | NAV as of Oct 02, 2024 | 1-Day Return as of Oct 02, 2024, 10:24 PM GMT+0

Morningstar’s Analysis MEDIX

Will MEDIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A strong management team and sound investment process underpin MFS Emerging Markets Debt I's Morningstar Medalist Rating of Silver.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the second-lowest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings MEDIX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 14.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Currency Cash CASH_USD

6.31 458.1 Mil
Cash and Equivalents

United States Treasury Notes 2.75%

2.89 209.9 Mil
Government

5 Year Treasury Note Future Dec 24

2.80 203.4 Mil
Government

USD/EUR FWD 20241018 Purchased

2.73 198.4 Mil
Derivative

EUR/USD FWD 20241018 Purchased

2.23 161.7 Mil
Derivative

UST Bond 30Yr Future DEC 19 24

1.64 118.9 Mil
Government

10 Year Treasury Note Future Dec 24

1.49 108.2 Mil
Government

Oman (Sultanate Of) 6.75%

1.41 102.5 Mil
Government

USD/BRL NDF 20240927 Purchased

1.40 101.7 Mil
Derivative

Oman (Sultanate Of) 7%

1.24 89.9 Mil
Government

Sponsor Center